Temilade Patience Adejumo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Temilade Patience Adejumo has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Emmanuel Oyedeji Oyetola
Ladoke Akintola University of Technology, Ogbomoso, Nigeria
2 shared publications - Habiblah Ayomide Jagunmolu
Ladoke Akintola University of Technology, Ogbomoso, Nigeria
2 shared publications - Nicholas Aderinto
Ladoke Akintola University of Technology, Ogbomosho, Nigeria
2 shared publications - Samuel Oyeponle Oyelude
Ladoke Akintola University of Technology, Ogbomoso, Nigeria
2 shared publications - Abdulbasit Opeyemi Muili
Medical Student, Department of Medicine, Ladoke Akintola University of Technology, Ibadan, Oyo, Nigeria. Scientific Editor (incoming), IJMS
1 shared publication - Abdulhafiz Ashiru
Ulster Hospital, Dundonald, Northern Ireland, Belfast, UK
1 shared publication
Latest Publications
- Open Access
- 14 September 2026
- Published by Springer Nature in The Egyptian Heart Journal
- Vol. 78 (1) , 66
Identification and reporting of heart failure with preserved ejection fraction in Sub-Saharan Africa: a scoping review of diagnostic approaches, echocardiographic assessment, and evidence gaps
Background: Heart failure with preserved ejection fraction (HFpEF) is increasingly recognized as a major heart failure phenotype globally; however, its diagnosis is complex and is recommended to require integrated assessment of clinical features, echocardiographic abnormalities, and biomarkers. In Sub-Saharan Africa (SSA), where diagnostic resources are limited, HFpEF identification may rely on simplified approaches, potentially leading to under-recognition and heterogeneity in reporting. This review evaluates how HFpEF is identified and reported in SSA, with emphasis on diagnostic approaches, echocardiographic characterization, and biomarker use. Methods: A scoping review of observational studies reporting heart failure with left ventricular ejection fraction (LVEF) data in Sub-Saharan Africa (SSA) was conducted using predefined eligibility criteria and reported in accordance with PRISMA-ScR. PubMed, Google Scholar, Web of Science, and African Journals Online (AJOL) were searched for relevant studies published in English from database inception to May 2026. Data were extracted on HFpEF definitions, echocardiographic parameters, biomarker use, and diagnostic approaches and frameworks used during the respective study periods. Contemporary HFpEF diagnostic frameworks, including HFA-PEFF and H₂FPEF, were considered separately when interpreting the compatibility of reported phenotyping approaches with current diagnostic concepts. Results: 10 observational studies involving 3,821 patients with heart failure, published between 2009 and 2024, were included. Studies were conducted in South Africa, Nigeria, Senegal, Côte d’Ivoire, Cameroon, and Tanzania, with two multicountry Sub-Saharan African registries also represented. HFpEF definitions were inconsistent, with most studies relying primarily on LVEF ≥ 50% without application of structured diagnostic algorithms. Only two studies reported dedicated HFpEF cohorts, while the remainder identified HFpEF as a subgroup within broader heart failure populations. Echocardiographic reporting was highly variable; left ventricular hypertrophy and left atrial enlargement were the most frequently reported structural abnormalities, but diastolic function parameters were inconsistently assessed, and formal grading was rare. Natriuretic peptides were infrequently measured and seldom integrated into diagnostic classification. No study applied contemporary multiparametric diagnostic frameworks such as HFA-PEFF or H₂FPEF scoring systems. Conclusion: HFpEF in SSA is predominantly identified using simplified ejection fraction-based criteria, with limited integration of echocardiographic diastolic assessment and biomarker data. This results in heterogeneous and potentially non-standardized phenotyping across studies, limiting comparability and accurate disease estimation. Strengthening diagnostic standardization through structured echocardiographic reporting, improved access to natriuretic peptide testing, and consideration of adapted multiparametric HFpEF algorithms may help improve diagnostic consistency and research quality in the region. These findings should be interpreted in the context of the heterogeneous and predominantly hospital-based evidence currently available from SSA.
- 14 September 2026
- Published by Springer Nature in The Egyptian Heart Journal
- Vol. 78 (1) , 66
Open AccessIdentification and reporting of heart failure with preserved ejection fraction in Sub-Saharan Africa: a scoping review of diagnostic approaches, echocardiographic assessment, and evidence gaps
Background: Heart failure with preserved ejection fraction (HFpEF) is increasingly recognized as a major heart failure phenotype globally; however, its diagnosis is complex and is recommended to require integrated assessment of clinical features, echocardiographic abnormalities, and biomarkers. In Sub-Saharan Africa (SSA), where diagnostic resources are limited, HFpEF identification may rely on simplified approaches, potentially leading to under-recognition and heterogeneity in reporting. This review evaluates how HFpEF is identified and reported in SSA, with emphasis on diagnostic approaches, echocardiographic characterization, and biomarker use. Methods: A scoping review of observational studies reporting heart failure with left ventricular ejection fraction (LVEF) data in Sub-Saharan Africa (SSA) was conducted using predefined eligibility criteria and reported in accordance with PRISMA-ScR. PubMed, Google Scholar, Web of Science, and African Journals Online (AJOL) were searched for relevant studies published in English from database inception to May 2026. Data were extracted on HFpEF definitions, echocardiographic parameters, biomarker use, and diagnostic approaches and frameworks used during the respective study periods. Contemporary HFpEF diagnostic frameworks, including HFA-PEFF and H₂FPEF, were considered separately when interpreting the compatibility of reported phenotyping approaches with current diagnostic concepts. Results: 10 observational studies involving 3,821 patients with heart failure, published between 2009 and 2024, were included. Studies were conducted in South Africa, Nigeria, Senegal, Côte d’Ivoire, Cameroon, and Tanzania, with two multicountry Sub-Saharan African registries also represented. HFpEF definitions were inconsistent, with most studies relying primarily on LVEF ≥ 50% without application of structured diagnostic algorithms. Only two studies reported dedicated HFpEF cohorts, while the remainder identified HFpEF as a subgroup within broader heart failure populations. Echocardiographic reporting was highly variable; left ventricular hypertrophy and left atrial enlargement were the most frequently reported structural abnormalities, but diastolic function parameters were inconsistently assessed, and formal grading was rare. Natriuretic peptides were infrequently measured and seldom integrated into diagnostic classification. No study applied contemporary multiparametric diagnostic frameworks such as HFA-PEFF or H₂FPEF scoring systems. Conclusion: HFpEF in SSA is predominantly identified using simplified ejection fraction-based criteria, with limited integration of echocardiographic diastolic assessment and biomarker data. This results in heterogeneous and potentially non-standardized phenotyping across studies, limiting comparability and accurate disease estimation. Strengthening diagnostic standardization through structured echocardiographic reporting, improved access to natriuretic peptide testing, and consideration of adapted multiparametric HFpEF algorithms may help improve diagnostic consistency and research quality in the region. These findings should be interpreted in the context of the heterogeneous and predominantly hospital-based evidence currently available from SSA.
- 24 August 2026
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 20 (1) , 877
Robotic-assisted total knee arthroplasty for severe fixed valgus deformity: a systematic review of alignment restoration, soft tissue balancing strategies, and clinical outcomes
Managing moderate-to-severe fixed valgus deformities in total knee arthroplasty (TKA) is technically demanding due to lateral compartment bony hypoplasia, contracted lateral soft tissues, and medial collateral ligament laxity. While conventional workflows often require extensive manual ligamentous releases, robotic-assisted TKA (RA-TKA) offers real-time digital gap balancing. This systematic review evaluates the clinical and radiographic efficacy of RA-TKA specifically isolating the moderate-to-severe fixed valgus morphotype. A systematic search of PubMed, Scopus, Google Scholar, and Cochrane CENTRAL was conducted from 27th of May 2026 to 1st of June 2026. The study was prospectively registered on PROSPERO, and clinical studies evaluating primary RA-TKA for fixed valgus deformities (at least 100, or Krackow Type II or III) were included. Methodological quality was assessed using the ROBINS-I tool and JBI Critical Appraisal Checklist. Thirteen studies comprising 1,787 robotic-assisted TKAs were included. Improvements from preoperative to postoperative coronal alignment were consistently achieved, with mean postoperative hip-knee-ankle angles restored to within 10-30 of surgical targets and low outlier rates (<20% across robotic cohorts compared to up to 42.3% in manual controls). Functional Alignment cohorts consistently achieved 0% manual soft-tissue release rate. Conversely, Mechanical Alignment (MA) cohorts required selective lateral releases (primarily the iliotibial band and popliteus tendon) in 38.5% to 71.4% of cases. Robotic-assisted TKA is a safe and highly precise tool for managing the complex valgus morphotype. It provides excellent coronal alignment restoration and facilitates a major de-escalation of surgical trauma, allowing surgeons to achieve stability with standard, lower-constraint implants. Level of Evidence: Level IV
- 24 August 2026
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 20 (1) , 877
Robotic-assisted total knee arthroplasty for severe fixed valgus deformity: a systematic review of alignment restoration, soft tissue balancing strategies, and clinical outcomes
Managing moderate-to-severe fixed valgus deformities in total knee arthroplasty (TKA) is technically demanding due to lateral compartment bony hypoplasia, contracted lateral soft tissues, and medial collateral ligament laxity. While conventional workflows often require extensive manual ligamentous releases, robotic-assisted TKA (RA-TKA) offers real-time digital gap balancing. This systematic review evaluates the clinical and radiographic efficacy of RA-TKA specifically isolating the moderate-to-severe fixed valgus morphotype. A systematic search of PubMed, Scopus, Google Scholar, and Cochrane CENTRAL was conducted from 27th of May 2026 to 1st of June 2026. The study was prospectively registered on PROSPERO, and clinical studies evaluating primary RA-TKA for fixed valgus deformities (at least 100, or Krackow Type II or III) were included. Methodological quality was assessed using the ROBINS-I tool and JBI Critical Appraisal Checklist. Thirteen studies comprising 1,787 robotic-assisted TKAs were included. Improvements from preoperative to postoperative coronal alignment were consistently achieved, with mean postoperative hip-knee-ankle angles restored to within 10-30 of surgical targets and low outlier rates (<20% across robotic cohorts compared to up to 42.3% in manual controls). Functional Alignment cohorts consistently achieved 0% manual soft-tissue release rate. Conversely, Mechanical Alignment (MA) cohorts required selective lateral releases (primarily the iliotibial band and popliteus tendon) in 38.5% to 71.4% of cases. Robotic-assisted TKA is a safe and highly precise tool for managing the complex valgus morphotype. It provides excellent coronal alignment restoration and facilitates a major de-escalation of surgical trauma, allowing surgeons to achieve stability with standard, lower-constraint implants. Level of Evidence: Level IV
- Top Cited PapersOpen Access
- 7 August 2023
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 85 (9) , 4425-4432
Exploring the transformative influence of neuroplasticity on stroke rehabilitation: a narrative review of current evidence
This review aims to assess the role of neuroplasticity in facilitating stroke recovery and identify the challenges and limitations associated with its implementation. A comprehensive literature search was conducted to identify relevant studies, which were meticulously evaluated to determine the potential solutions for effectively harnessing neuroplasticity. The results indicate that neuroplasticity holds significant promise in stroke rehabilitation; however, individual variability in response to interventions, timing and duration of interventions and sociocultural and clinical factors pose challenges. Tailoring interventions to individual patient characteristics is crucial for optimising the impact of neuroplasticity. Despite challenges and limitations, the transformative potential of neuroplasticity in stroke rehabilitation is undeniable. The abstract concludes by emphasising the importance of a comprehensive understanding of individual variability, optimising intervention timing and duration and considering sociocultural and clinical factors. Future research and clinical practice should prioritise personalised interventions and interdisciplinary collaborations to fully exploit the vast potential of neuroplasticity in stroke recovery.
- 7 August 2023
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 85 (9) , 4425-4432
Top Cited PapersOpen AccessExploring the transformative influence of neuroplasticity on stroke rehabilitation: a narrative review of current evidence
This review aims to assess the role of neuroplasticity in facilitating stroke recovery and identify the challenges and limitations associated with its implementation. A comprehensive literature search was conducted to identify relevant studies, which were meticulously evaluated to determine the potential solutions for effectively harnessing neuroplasticity. The results indicate that neuroplasticity holds significant promise in stroke rehabilitation; however, individual variability in response to interventions, timing and duration of interventions and sociocultural and clinical factors pose challenges. Tailoring interventions to individual patient characteristics is crucial for optimising the impact of neuroplasticity. Despite challenges and limitations, the transformative potential of neuroplasticity in stroke rehabilitation is undeniable. The abstract concludes by emphasising the importance of a comprehensive understanding of individual variability, optimising intervention timing and duration and considering sociocultural and clinical factors. Future research and clinical practice should prioritise personalised interventions and interdisciplinary collaborations to fully exploit the vast potential of neuroplasticity in stroke recovery.